Current Indications and Overview of Molecular Imaging Techniques in Stem Cell Transplantation

Author(s):  
Tarun Pandey
2006 ◽  
Vol 8 (2) ◽  
pp. 147-154 ◽  
Author(s):  
Ahmad Y. Sheikh ◽  
Joseph C. Wu

2012 ◽  
Vol 8 (4) ◽  
pp. 1265-1266 ◽  
Author(s):  
Nora Sandu ◽  
Toma Spiriev ◽  
Bernhard Schaller

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Ping Wang ◽  
Francesco Petrella ◽  
Luca Nicosia ◽  
Massimo Bellomi ◽  
Stefania Rizzo

Stem cell transplantation has been investigated to rescue experimental liver failure and is promising to offer an alternative therapy to liver transplantation for liver diseases treatment. Several clinical studies in this field have been carried out, but the therapeutic benefit of this treatment is still controversial. A major obstacle to developing stem cell therapies in clinic is being able to visualize the cells in vivo. Imaging modalities allow optimization of delivery, detecting cell survival and functionality by in vivo monitoring these transplanted graft cells. Moreover, theranostic imaging is a brand new field that utilizes nanometer-scale materials to glean diagnostic insight for simultaneous treatment, which is very promising to improve stem cell-based therapy for treatment of liver diseases. The aim of this review was to summarize the various imaging tools that have been explored with advanced molecular imaging probes. We also outline some recent progress of preclinical and clinical studies of liver stem cells transplantation. Finally, we discuss theranostic imaging for stem cells transplantation for liver dysfunction and future opportunities afforded by theranostic imaging.


2017 ◽  
Vol 174 ◽  
pp. 1380-1386
Author(s):  
Guo Donghai ◽  
Wang Qiangli ◽  
Han Xiaojing ◽  
Luo Zhirong ◽  
Zhang Lisheng

2010 ◽  
Vol 16 (9-10) ◽  
pp. 433-437 ◽  
Author(s):  
Nora Sandu ◽  
Bernhard Schaller

PRILOZI ◽  
2019 ◽  
Vol 40 (1) ◽  
pp. 81-86 ◽  
Author(s):  
Aleksandra Pivkova Veljanovska ◽  
Zlate Stojanoski ◽  
Lazar Chadievski ◽  
Irina Panovska Stavridis ◽  
Sanja Trajkova ◽  
...  

Abstract Posterior reversible encephalopathy syndrome (PRES) is one of the most serious complication after allogeneic stem cell transplantation in paediatric setting. It is most commonly reported as adverse event of immunosuppressive strategies during transplantation. We present a case of a 7 years old girl with myelodysplastic syndrome (MDS) treated with allogeneic stem cell transplantation (ASCT) at our department. Diagnosis of PRES was confirmed by imaging techniques during the first month after transplant and it was very likely connected with cyclosporine neurotoxicity. The aim of this article is to present our first experience in diagnosing and treating PRES in paediatric stem cell transplantation. Our experience showed that PRES is one of the reasons for higher transplant related mortality in children. Early prediction of factors contributing to PRES and closely monitoring of patient’s vital signs, especially blood pressure, neurological status and vision are the main contributors for challenging the patient with another immunosuppressive agent that has less neurological toxicity. Still studies have to be initiated to confirm the influence of PRES on transplant outcome.


2012 ◽  
Vol 9 (2) ◽  
pp. 60-67 ◽  
Author(s):  
Nora Sandu ◽  
Fatemeh Momen-Heravi ◽  
Pooyan Sadr-Eshkevari ◽  
Bernhard Schaller

Sign in / Sign up

Export Citation Format

Share Document